Advances, opportunities, and challenges in methods for interrogating the structure activity relationships of natural products

被引:5
作者
Ancajas, Christine Mae F. [1 ]
Oyedele, Abiodun S. [1 ]
Butt, Caitlin M. [1 ]
Walker, Allison S. [1 ,2 ,3 ]
机构
[1] Vanderbilt Univ, Dept Chem, Nashville, TN 37240 USA
[2] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37240 USA
[3] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37240 USA
基金
美国国家卫生研究院;
关键词
BIOSYNTHETIC GENE-CLUSTER; ENANTIOSELECTIVE TOTAL-SYNTHESIS; SOLID-PHASE SYNTHESIS; NONRIBOSOMAL PEPTIDE; DRUG DISCOVERY; COMBINATORIAL BIOSYNTHESIS; POLYKETIDE SYNTHASE; TEIXOBACTIN ANALOGS; MOLECULAR DOCKING; ANTIBACTERIAL ACTIVITY;
D O I
10.1039/d4np00009a
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Time span in literature: 1985-early 2024Natural products play a key role in drug discovery, both as a direct source of drugs and as a starting point for the development of synthetic compounds. Most natural products are not suitable to be used as drugs without further modification due to insufficient activity or poor pharmacokinetic properties. Choosing what modifications to make requires an understanding of the compound's structure-activity relationships. Use of structure-activity relationships is commonplace and essential in medicinal chemistry campaigns applied to human-designed synthetic compounds. Structure-activity relationships have also been used to improve the properties of natural products, but several challenges still limit these efforts. Here, we review methods for studying the structure-activity relationships of natural products and their limitations. Specifically, we will discuss how synthesis, including total synthesis, late-stage derivatization, chemoenzymatic synthetic pathways, and engineering and genome mining of biosynthetic pathways can be used to produce natural product analogs and discuss the challenges of each of these approaches. Finally, we will discuss computational methods including machine learning methods for analyzing the relationship between biosynthetic genes and product activity, computer aided drug design techniques, and interpretable artificial intelligence approaches towards elucidating structure-activity relationships from models trained to predict bioactivity from chemical structure. Our focus will be on these latter topics as their applications for natural products have not been extensively reviewed. We suggest that these methods are all complementary to each other, and that only collaborative efforts using a combination of these techniques will result in a full understanding of the structure-activity relationships of natural products. This review highlights methods for studying structure activity relationships of natural products and proposes that these methods are complementary and could be used to build an iterative computational-experimental workflow.
引用
收藏
页码:1543 / 1578
页数:36
相关论文
共 409 条
  • [11] Comprehensive Structure-Activity Relationship Studies of Cepafungin Enabled by Biocatalytic C-H Oxidations
    Amatuni, Alexander
    Shuster, Anton
    Abegg, Daniel
    Adibekian, Alexander
    Renata, Hans
    [J]. ACS CENTRAL SCIENCE, 2023, 9 (02) : 239 - 251
  • [12] Virtual and In Vitro Screening of Natural Products Identifies Indole and Benzene Derivatives as Inhibitors of SARS-CoV-2 Main Protease (Mpro)
    Ang, Dony
    Kendall, Riley
    Atamian, Hagop S.
    [J]. BIOLOGY-BASEL, 2023, 12 (04):
  • [13] Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature
    Arnison, Paul G.
    Bibb, Mervyn J.
    Bierbaum, Gabriele
    Bowers, Albert A.
    Bugni, Tim S.
    Bulaj, Grzegorz
    Camarero, Julio A.
    Campopiano, Dominic J.
    Challis, Gregory L.
    Clardy, Jon
    Cotter, Paul D.
    Craik, David J.
    Dawson, Michael
    Dittmann, Elke
    Donadio, Stefano
    Dorrestein, Pieter C.
    Entian, Karl-Dieter
    Fischbach, Michael A.
    Garavelli, John S.
    Goeransson, Ulf
    Gruber, Christian W.
    Haft, Daniel H.
    Hemscheidt, Thomas K.
    Hertweck, Christian
    Hill, Colin
    Horswill, Alexander R.
    Jaspars, Marcel
    Kelly, Wendy L.
    Klinman, Judith P.
    Kuipers, Oscar P.
    Link, A. James
    Liu, Wen
    Marahiel, Mohamed A.
    Mitchell, Douglas A.
    Moll, Gert N.
    Moore, Bradley S.
    Mueller, Rolf
    Nair, Satish K.
    Nes, Ingolf F.
    Norris, Gillian E.
    Olivera, Baldomero M.
    Onaka, Hiroyasu
    Patchett, Mark L.
    Piel, Joern
    Reaney, Martin J. T.
    Rebuffat, Sylvie
    Ross, R. Paul
    Sahl, Hans-Georg
    Schmidt, Eric W.
    Selsted, Michael E.
    [J]. NATURAL PRODUCT REPORTS, 2013, 30 (01) : 108 - 160
  • [14] Engineered Biosynthesis of Pharmaceutically Important Compounds
    Awakawa, Takayoshi
    [J]. CHEMICAL & PHARMACEUTICAL BULLETIN, 2021, 69 (05) : 415 - 420
  • [15] Reprogramming of the antimycin NRPS-PKS assembly lines inspired by gene evolution
    Awakawa, Takayoshi
    Fujioka, Takuma
    Zhang, Lihan
    Hoshino, Shotaro
    Hu, Zhijuan
    Hashimoto, Junko
    Kozone, Ikuko
    Ikeda, Haruo
    Shin-Ya, Kazuo
    Liu, Wen
    Abe, Ikuro
    [J]. NATURE COMMUNICATIONS, 2018, 9
  • [16] On Pixel-Wise Explanations for Non-Linear Classifier Decisions by Layer-Wise Relevance Propagation
    Bach, Sebastian
    Binder, Alexander
    Montavon, Gregoire
    Klauschen, Frederick
    Mueller, Klaus-Robert
    Samek, Wojciech
    [J]. PLOS ONE, 2015, 10 (07):
  • [17] A comparison between 2D and 3D descriptors in QSAR modeling based on bio-active conformations
    Bahia, Malkeet Singh
    Kaspi, Omer
    Touitou, Meir
    Binayev, Idan
    Dhail, Seema
    Spiegel, Jacob
    Khazanov, Netaly
    Yosipof, Abraham
    Senderowitz, Hanoch
    [J]. MOLECULAR INFORMATICS, 2023, 42 (04)
  • [18] Bajorath Jurgen, 2015, F1000Res, V4, DOI 10.12688/f1000research.6653.1
  • [19] Baldassarre F, 2019, ARXIV
  • [20] Baltz R. H., 2014, NATURAL PRODUCTS